Jun. 25 at 9:37 PM
$SANA i may be starry eyed & overly optimistic, but im of the inclination that if sc451 works as well as uppsala pt, the fda/nih whoever, steps in and speeds this way up. Like snap approval after p2 w/ post mkt p3. Again assuming it works like it has in the one pt. Big if, but if no sae’s and it’s really a cure, they aren’t going to put it off for yrs. Not this fda. The rub is one pt, can it do the same in 12-20? 50-100?
Also think the pps would be @
$5-7 right now if the “as” was an “in”. Like “early in 2026”, not “early as 2026”. That could be end of ‘26! Almost 2 yrs to submit an nda for a cure is ridiculous. This isn’t some cns drug who’s effectiveness depends on holding your head right and squinting one eye to see it. It’s a cure for t1d. A plague on humans documented from the time of the pyramids. Do they really think the fda is gonna nitpick them on the Nda for a cure? Get it in the dam clinic! Putting it off that long is a red flag to some/many. LFG
